Skip to main content
. 2016 Feb 9;65(6):1511–1520. doi: 10.2337/db15-1552

Figure 1.

Figure 1

Intracerebroventricular (ICV) insulin infusion increases TG secretion. A: Protocol. B: Plasma insulin concentration at baseline (−60 min), at the end (180 min) of the intracerebroventricular insulin infusion, and after intravenous (IV) insulin infusion (n ≥ 5/group). C: Plasma TG accumulation in intracerebroventricular or intravenous insulin– and tyloxapol–injected rats (n ≥ 5/group, except intravenous insulin group: n = 4). D: The calculated VLDL secretion rate combining two independent experimental cohorts (n ≥ 11/group, except intravenous insulin group: n = 5). E: Plasma FA profiles as assessed by gas chromatography; depicted are the absolute changes from time point 0–180 min (n ≥ 6/group). All error bars are SEM. *P < 0.05, **P < 0.01, ***P < 0.001 vs. intracerebroventricular vehicle group; §P < 0.05, §§P < 0.01, §§§P < 0.001 vs. intracerebroventricular insulin group.